These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32942038)

  • 41. Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis.
    He L; Liu T; Shi Y; Tian F; Hu H; Deb DK; Chen Y; Bissonnette M; Li YC
    Endocrinology; 2018 Feb; 159(2):967-979. PubMed ID: 29228157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status.
    Garg M; Royce SG; Tikellis C; Shallue C; Sluka P; Wardan H; Hosking P; Monagle S; Thomas M; Lubel JS; Gibson PR
    Therap Adv Gastroenterol; 2019; 12():1756284818822566. PubMed ID: 30719077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1/Nrf2 and NF-κB dependent mechanism in Caco-2 cells.
    Yao B; He J; Yin X; Shi Y; Wan J; Tian Z
    Toxicol Lett; 2019 Nov; 316():109-118. PubMed ID: 31472180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
    Front Immunol; 2018; 9():363. PubMed ID: 29535731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease.
    Rodríguez-Feo JA; Puerto M; Fernández-Mena C; Verdejo C; Lara JM; Díaz-Sánchez M; Álvarez E; Vaquero J; Marín-Jiménez I; Bañares R; Menchén L
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G981-93. PubMed ID: 25907690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease.
    Kosinsky RL; Zerche M; Kutschat AP; Nair A; Ye Z; Saul D; von Heesen M; Friton JJ; Schwarzer AC; Paglilla N; Sheikh SZ; Wegwitz F; Sun Z; Ghadimi M; Newberry RD; Sartor RB; Faubion WA; Johnsen SA
    Cell Death Differ; 2021 Nov; 28(11):3161-3175. PubMed ID: 34088983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammation- and Gut-Homing Macrophages, Engineered to
    Xu Y; Baylink DJ; Cao H; Xiao J; Abdalla MI; Wasnik S; Tang X
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the Role of Vitamin D and the Vitamin D Receptor in the Composition of the Gut Microbiota.
    Aggeletopoulou I; Tsounis EP; Mouzaki A; Triantos C
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):116. PubMed ID: 37395032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome.
    Ghaly S; Hart PH; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1039-1048. PubMed ID: 31657973
    [No Abstract]   [Full Text] [Related]  

  • 51. Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.
    Zhang YG; Lu R; Xia Y; Zhou D; Petrof E; Claud EC; Sun J
    Inflamm Bowel Dis; 2019 Jan; 25(1):97-110. PubMed ID: 30289450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling.
    Domazetovic V; Iantomasi T; Bonanomi AG; Stio M
    Int J Colorectal Dis; 2020 Jul; 35(7):1231-1242. PubMed ID: 32314188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probiotics and Vitamin D/Vitamin D Receptor Pathway Interaction: Potential Therapeutic Implications in Inflammatory Bowel Disease.
    Pagnini C; Di Paolo MC; Graziani MG; Delle Fave G
    Front Pharmacol; 2021; 12():747856. PubMed ID: 34899302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
    Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
    Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal Epithelial Cell-specific Deletion of α-Mannosidase II Ameliorates Experimental Colitis.
    Suzuki K; Yamada T; Yamazaki K; Hirota M; Ishihara N; Sakamoto M; Takahashi D; Iijima H; Hase K
    Cell Struct Funct; 2018 Mar; 43(1):25-39. PubMed ID: 29343654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal epithelial cells in inflammatory bowel diseases.
    Roda G; Sartini A; Zambon E; Calafiore A; Marocchi M; Caponi A; Belluzzi A; Roda E
    World J Gastroenterol; 2010 Sep; 16(34):4264-71. PubMed ID: 20818809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?
    O'Sullivan M
    Proc Nutr Soc; 2015 Feb; 74(1):5-12. PubMed ID: 25490986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency.
    Golan MA; Liu W; Shi Y; Chen L; Wang J; Liu T; Li YC
    Dig Dis Sci; 2015 Jul; 60(7):1941-7. PubMed ID: 25894930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D in inflammatory bowel disease: From biology to clinical implications.
    Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Mottaghi-Moghaddam A; Ghazaghi A; Ghandehari M; Alizade-Noghani M; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Parizadeh SMR; Avan A
    Complement Ther Med; 2019 Dec; 47():102189. PubMed ID: 31779998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mucus protectors: Promising therapeutic strategies for inflammatory bowel disease.
    Wu HM; Wei J; Wang K; Qi Y; Wang FY
    Med Hypotheses; 2018 Nov; 120():55-59. PubMed ID: 30220341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.